e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Methodology in epidemiologic research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Screening for alpha-1 antitrypsin deficiency in Germany – Update 2012
T. Greulich, A. Klemmer, S. Schroth, C. Nell, V. Kotke, S. Wiedmann, C. Herr, C.F. Vogelmeier, R. Bals, A.R. Koczulla (Marburg, Homburg/Saar, Germany)
Source:
Annual Congress 2012 - Methodology in epidemiologic research
Session:
Methodology in epidemiologic research
Session type:
Thematic Poster Session
Number:
3957
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Greulich, A. Klemmer, S. Schroth, C. Nell, V. Kotke, S. Wiedmann, C. Herr, C.F. Vogelmeier, R. Bals, A.R. Koczulla (Marburg, Homburg/Saar, Germany). Screening for alpha-1 antitrypsin deficiency in Germany – Update 2012. Eur Respir J 2012; 40: Suppl. 56, 3957
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Implementation of screening program for alpha-1 antitrypsin deficiency in Spain
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004
Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Year: 2021
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
α1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001
Source: Eur Respir J 2002; 20: 1050-1056
Year: 2002
Nutritional risk screening 2002 – Application in pneumology
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012
Intra-epithelial polymerization, accumulation and secretion of alpha
1
antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Epithelial cell biology
Year: 2010
Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil
Source: Eur Respir J 2003; 22: Suppl. 45, 499s
Year: 2003
Clinical decision making in alpha
1
antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV
1
decline
Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases
Year: 2010
ATS / ERS: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency
Source: Guideline 2003
Year: 2003
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Prevalence of alpha-1 antitrypsin deficiency (AATD) in Greater Glasgow and Clyde (GG&C) and current practises
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Preliminary results from newborn screening
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Molecular diagnosis of Alpha-1 antitrypsin deficiency: a new method based on Luminex Technology
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Late Breaking Abstract - Genetic diagnosis of alpha-1 antitrypsin deficiency using saliva samples
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
Association between alpha 1 antitrypsin and bronchiectasis
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept